Annual report from the American Cancer Society says HIV is an underlying factor in a handful of cancer diagnoses.
In those with human immunodeficiency virus (HIV), there is a 10-fold higher cancer risk than in the general population, according to the annual Cancer Facts and Figures report from the American Cancer Society published today.
Cancer rates in HIV-positive individuals have decreased since the introduction of highly active antiretroviral therapy (HAART). Since HAART became available in 1996, there has been a 70% drop in Kaposi sarcoma and a 50% drop in non-Hodgkin lymphoma in those with HIV.
Because HIV compromises the immune system, it increases the risk of infections like human papillomavirus (HPV) that can lead to cervical cancer. Ten cancers are associated with HIV. These include non-Hodgkin lymphoma, cervical, liver, anal, and lung cancers.
LGBTQ+ (lesbian, gay, bisexual, transgender, and queer) individuals experience higher rates of HIV. For example, in 2019, 70% of HIV infections were attributed to male-to-male sexual contact.
The LGBTQ+ community experiences higher rates of health disparities overall. This is due to minority stress which the report defines as “the discrepancy and conflict that arises between the values of a historically minoritized group and the dominant culture or society.”
These stressors lead to higher rates of smoking, excess body weight, and alcohol consumption, which are all more prevalent in LBGTQ+ people than in heterosexuals. This can lead to lung cancer
Access to care is another barrier for the community. There are still nine states where it is legal for healthcare professionals to refuse to care for LGBTQ+ patients: Alabama, Arkansas, Florida, Illinois, Mississippi, Montana, Ohio, South Carolina, and Tennessee. The patients in these states account for an estimated 20% of the entire LGBTQ+ population.
Trump Budget Axes CDC HIV Prevention, Shifts Care, Experts Warn of Risks
June 10th 2025Although some HIV programs will remain, the proposed cuts in the fiscal year 2026 budget are too severe and will hinder HIV care and research in the United States, according to Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C.
Read More
Most HIV Patients Trust Their Providers But Don’t Always Feel Heard, Survey Says
May 27th 2025Almost half (48%) of HIV patients sometimes feel unheard by their healthcare providers, which highlights a need for increased disease awareness, according to the early results of a new ViiV Healthcare survey.
Read More
HIV Antiretroviral Reduced Alzheimer’s Risk Continuously, Study Shows
May 8th 2025Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of Alzheimer’s disease by an average of 9% every year, according to new research published in Alzheimer’s and Dementia.
Read More